Canature Health Technology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Yaming Qu
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Canature Health Technology's (SZSE:300272) Soft Earnings Are Actually Better Than They Appear
Nov 04
There's No Escaping Canature Health Technology Co., Ltd.'s (SZSE:300272) Muted Earnings Despite A 48% Share Price Rise
Oct 08We Like These Underlying Return On Capital Trends At Canature Health Technology (SZSE:300272)
Sep 30Canature Health Technology (SZSE:300272) Is Paying Out A Dividend Of CN¥0.10
May 27Market Might Still Lack Some Conviction On Canature Health Technology Co., Ltd. (SZSE:300272) Even After 28% Share Price Boost
May 08Canature Health Technology's (SZSE:300272) Earnings Offer More Than Meets The Eye
Apr 29Here's Why We Think Canature Health Technology (SZSE:300272) Is Well Worth Watching
Apr 01CEO
Yaming Qu (45 yo)
12.7yrs
Tenure
CN¥1,298,300
Compensation
Mr. Raymond Ming Qu, also known as Yaming, has been General Manager of Canature Health Technology Group Co., Ltd. (formerly known as Shanghai Canature Environmental Products Co., Ltd.), serves as its Vice...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Vice Chairman | 12.7yrs | CN¥1.30m | no data | |
| Deputy GM & Non Independent Director | 4.5yrs | CN¥511.00k | 0.028% CN¥ 1.0m | |
| Chairman | 4.5yrs | CN¥316.00k | 34.45% CN¥ 1.3b | |
| Chairman of the Supervisory Board | 6.5yrs | no data | no data | |
| Supervisor | 3.6yrs | no data | no data | |
| Independent Director | 1.6yrs | CN¥60.00k | no data | |
| Independent Director | 1.6yrs | CN¥60.00k | no data |
4.5yrs
Average Tenure
55yo
Average Age
Experienced Board: 300272's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 12:26 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Canature Health Technology Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pu Du | Bohai Securities Co., Ltd. |
| Jianxiong Wu | Central China Securities Co., Ltd. |
| Chun Xu | Changjiang Securities Co. LTD. |